Missing/wrong data?
Log in to edit
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
scientific article
Author/s
author: Sergio Giralt, Elizabeth J Shpall, Richard E Champlin, Peter F Thall, Martin Körbling, Betty Pierre, Roy B. Jones
Work details
Publication date
June 1, 2008
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.